The PCSK9 gene helps control how much LDL, often called bad cholesterol, stays in your blood by influencing how the liver removes it. If it is too active, LDL levels can rise and increase the chance of heart disease; if it works less, LDL can be unusually low, often without symptoms. This gene can play a role in how your body responds to cholesterol lowering treatment. Public awareness grew when PCSK9 inhibitor medicines became a new option for people with inherited high cholesterol and some forms of cardiovascular disease.
What is a gene?
Genes are stretches of DNA that give your cells instructions for making molecules or managing activities in the body. Some genes carry the code for producing proteins, the parts of cells that do much of the work. Other genes mainly regulate when certain processes happen, where they happen, and how strongly they are turned on. As a group, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. To go into this topic in more detail, you can read more in the LearnHub.
Overview
PCSK9Gene function
What if the gene works
The PCSK9 gene helps control how your liver clears LDL cholesterol from your blood. Its protein adjusts LDL receptors on liver cells, helping keep cholesterol levels in balance.
Risk
What if the gene does not work
Variants in the PCSK9 gene can raise or lower LDL cholesterol, often called bad cholesterol. More severe changes often cause earlier, stronger LDL elevation and familial hypercholesterolemia, while variants that reduce PCSK9 activity lower LDL and can reduce coronary artery disease risk.
Treatment
What does that mean for your treatment
No PCSK9-specific treatment plan is currently established based on carrying a variant alone. Treatment is usually guided by LDL cholesterol levels and overall heart risk, although medicines that lower PCSK9 activity, including alirocumab, evolocumab, and inclisiran, are established options for some people with very high LDL cholesterol.
Conditions associated with PCSK9
Gene function
What if the gene works
Your body uses the PCSK9 gene to fine tune how cholesterol is cleared from the blood. It is most active in the liver, where it helps control the number of LDL receptors on cell surfaces. These receptors pull LDL cholesterol out of circulation, so this gene is part of your body’s normal cholesterol balancing system.
The PCSK9 gene makes a protein that attaches to LDL receptors, which are the cell’s docking points for LDL cholesterol. This helps liver cells decide whether those receptors are reused or broken down.
By shaping LDL receptor levels, the PCSK9 gene helps regulate how your body clears LDL cholesterol from the blood. This steady adjustment supports normal cholesterol balance from day to day.
The protein from the PCSK9 gene is produced mainly by the liver and released into the bloodstream, where it can reach LDL receptors on liver cells. This allows cholesterol handling to be coordinated across the body.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These differences are common and help make up normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the PCSK9 gene can make the protein overactive, less active, or missing, which changes how strongly it drives the removal of LDL receptors from liver cells. This is one of the main ways PCSK9 gene variants affect cholesterol handling in the body. Milder loss-of-function variants may only partly reduce protein activity, while more severe variants can greatly reduce or stop it. Gain-of-function variants can have the opposite effect and are linked to earlier or more marked LDL cholesterol elevation.
How variants are linked to conditions
Some variants in the PCSK9 gene cause familial hypercholesterolemia, an inherited condition that leads to very high LDL cholesterol from birth. This is the clearest link between the PCSK9 gene and high cholesterol, and it can raise the chance of early coronary artery disease. Other PCSK9 variants are associated with lower LDL levels and a lower risk of heart disease. Common risk-related variants can shift risk up or down, but they do not guarantee disease.
A variant is not necessarily a diagnosis
Genetic variants are a routine feature of human biology and are widely found across the general population. Most do not directly affect health and simply reflect normal human diversity. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences play a role. In some situations, though, one well-studied variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
Some PCSK9 changes can raise lifelong LDL cholesterol, which can increase the chance of early heart disease. That risk is also shaped by family history and other heart-health factors such as smoking, diabetes, high blood pressure, extra body weight, and a diet high in saturated fat.
Inheritance of PCSK9 variants
For families asking how PCSK9 gene variants are inherited, the usual pattern is autosomal dominant. This means a person with a disease-causing variant in one copy of the PCSK9 gene can pass it to a child with a 50% chance in each pregnancy, whether the child is male or female. In practice, this pattern is most often discussed for inherited high cholesterol linked to the PCSK9 gene, and it often appears across several generations of a family.
What does my PCSK9 result mean for my family?
PCSK9 results can matter for close relatives because changes in this gene often run in families. If your result is a PCSK9 change linked to very high LDL cholesterol, parents, brothers, sisters, and children may also carry it and may have a higher chance of early heart disease. Some PCSK9 changes do the opposite and lead to lower LDL cholesterol, so what it means for family members depends on the specific result.
Genetic information
Genetic testing
How you find out about variants
To find variants in the PCSK9 gene, PCSK9 genetic testing for inherited high cholesterol usually analyzes DNA from a blood or saliva sample. A lab reads the gene’s sequence to look for changes that may help explain very high LDL cholesterol and may also clarify whether a variant runs in a family.
When should I consider getting a genetic test?
Consider PCSK9 genetic testing if you or close relatives have very high LDL (“bad”) cholesterol, especially from childhood, or a strong family history of early heart disease. A result can help show whether an inherited cholesterol condition is part of the picture and may also help clarify risk for family members.
A genetic result is only one part of your health story
A genetic result can provide meaningful insight, but how much information it offers depends on the condition and the type of variant involved. How the body functions over time is shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best interpreted alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body absorbs, breaks down, transports, or responds to a drug. This helps explain why the same treatment works well for one person, has less effect in another, or causes more side effects in someone else. These differences are common and are one part of the bigger picture, along with age, other health conditions, and other medicines.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes can affect the way a person responds to medicines. By studying links between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medications, genes can influence how strongly a drug works or how the body handles it. This information can support treatment decisions that are better informed and more individualized. More on this topic is available in the LearnHub.
Drugs influenced by the PCSK9 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in routine medication decisions, so concerns about cholesterol treatment, side effects, or how well a medicine is working are best discussed with your doctor. Research on the PCSK9 gene has looked at whether inherited changes may affect response to some cholesterol-lowering medicines, but this is not yet used routinely to guide care.
History
The PCSK9 gene entered medicine in the early 2000s, when researchers studying families with very high cholesterol found that certain variants were linked to inherited high LDL cholesterol. Soon after, other variants in the same gene were connected with unusually low LDL levels and a lower chance of heart disease, which changed how scientists viewed cholesterol genetics. From these first observations, research expanded steadily. This unusually clear link between a gene and cholesterol levels helped drive the development of PCSK9-blocking medicines, a major step in preventive cardiology. The story of the PCSK9 gene is often highlighted as a rare example where human genetic findings moved relatively quickly into new treatment options. Today, it is seen as one of the landmark discoveries in cholesterol research.